Clinical Study on Adoptive Treatment of MDR-TB With Allogeneic γδT Cells

NCT03575299 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Multi-drug Resistant Tuberculosis

Interventions

BIOLOGICAL: The adoptive treatment of allogeneic γδT cells
OTHER: Control
DRUG: Conventional treatment

Sponsor

Zhinan Yin, Ph.D.

Collaborators

[object Object]